blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2637711

EP2637711 - INJECTABLE FORMULATIONS FOR ORGAN AUGMENTATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.02.2025
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  23.02.2024
FormerGrant of patent is intended
Status updated on  10.10.2023
FormerExamination is in progress
Status updated on  14.08.2023
FormerGrant of patent is intended
Status updated on  04.04.2023
FormerExamination is in progress
Status updated on  11.02.2022
FormerRequest for examination was made
Status updated on  05.12.2019
Most recent event   Tooltip13.03.2026Lapse of the patent in a contracting state
New state(s): HU		published on 15.04.2026 [2026/16]
Applicant(s)For all designated states
ProKidney
10 Market Street
No. 688 Camana Bay
Grand Cayman KY1-9006 / KY
[2023/39]
Former [2021/49]For all designated states
ProKidney
P.O. Box 309
Ugland House
South Church Street
George Town
Grand Kayman KY1-1104 / KY
Former [2013/38]For all designated states
Tengion, Inc.
2900 Potshop Lane, Suite 100
East Norriton, PA 19403 / US
Inventor(s)01 / BASU, Joydeep
435 Mica Court
Winston-Salem NC 27103 / US
02 / PAYNE, Richard
934 Franklin St.
Winston-Salem NC 27101 / US
03 / ROBBINS, Neil, F., Jr.
1111-5 Barbara Ann Circle
Winston-Salem NC 27103 / US
04 / KNIGHT, Oluwatoyin, A.
3919 Heatherview Lane
Winston-Salem NC 27127 / US
05 / JAIN, Deepak
559 Sun Creek Drive
Winston-Salem NC 27104 / US
06 / HALBERSTADT, Craig, R.
Winston-Salem
NC / US
07 / SERBAN, Monica, A.
188 Cameron Way Circle
Winston-Salem NC 27103 / US
 [2013/38]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2024/13]
Former [2014/23]Woolley, Lindsey Claire
Mewburn Ellis LLP
33 Gutter Lane
London
EC2V 8AS / GB
Former [2013/38]Kimblin, Nicola Claire
Mewburn Ellis LLP
33 Gutter Lane
London EC2V 8AS / GB
Application number, filing date11793523.910.11.2011
[2024/13]
WO2011US01887
Priority number, dateUS201161550184P21.10.2011         Original published format: US 201161550184 P
US20100412383P10.11.2010         Original published format: US 412383 P
US201161474278P12.04.2011         Original published format: US 201161474278 P
[2013/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012064369
Date:18.05.2012
Language:EN
[2012/20]
Type: A1 Application with search report 
No.:EP2637711
Date:18.09.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 18.05.2012 takes the place of the publication of the European patent application.
[2013/38]
Type: B1 Patent specification 
No.:EP2637711
Date:27.03.2024
Language:EN
[2024/13]
Search report(s)International search report - published on:EP18.05.2012
ClassificationIPC:A61L27/22, A61L27/38, A61L27/50, A61L27/52
[2013/38]
CPC:
A61L27/222 (EP,CN,KR,US); A61K9/0019 (KR); A61L27/3804 (CN);
A61K35/22 (KR,US); A61K45/06 (US); A61K9/06 (KR);
A61L27/52 (CN); A61L27/54 (EP,CN,KR,US); A61P13/12 (EP);
A61L2300/106 (CN); A61L2300/21 (CN); A61L2300/414 (CN);
A61L2300/426 (CN); A61L2400/06 (EP,CN,KR,US); A61L2430/26 (EP,CN,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/38]
Extension statesBA29.05.2013
ME29.05.2013
TitleGerman:INJIZIERBARE FORMULIERUNG FÜR ORGANAUGMENTATION[2013/38]
English:INJECTABLE FORMULATIONS FOR ORGAN AUGMENTATION[2013/38]
French:FORMULATIONS INJECTABLES POUR LA RÉGÉNÉRATION D'ORGANE[2013/38]
Entry into regional phase29.05.2013National basic fee paid 
29.05.2013Designation fee(s) paid 
29.05.2013Examination fee paid 
Examination procedure29.05.2013Examination requested  [2013/38]
13.02.2014Amendment by applicant (claims and/or description)
09.03.2015Application withdrawn by applicant  [2015/16]
deletedDeletion: Application withdrawn by applicant  [2020/01]
10.02.2022Despatch of a communication from the examining division (Time limit: M06)
18.08.2022Reply to a communication from the examining division
24.03.2023Cancellation of oral proceeding that was planned for 30.03.2023
30.03.2023Date of oral proceedings (cancelled)
05.04.2023Communication of intention to grant the patent
14.08.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
11.10.2023Communication of intention to grant the patent
19.02.2024Fee for grant paid
19.02.2024Fee for publishing/printing paid
19.02.2024Receipt of the translation of the claim(s)
Divisional application(s)EP24160615.1  / EP4403197
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.02.2022
Opposition(s)03.01.2025No opposition filed within time limit [2025/11]
Fees paidRenewal fee
18.11.2013Renewal fee patent year 03
10.11.2014Renewal fee patent year 04
10.11.2015Renewal fee patent year 05
10.11.2016Renewal fee patent year 06
13.11.2017Renewal fee patent year 07
14.11.2018Renewal fee patent year 08
28.10.2021Renewal fee patent year 09
28.10.2021Renewal fee patent year 10
28.10.2021Renewal fee patent year 11
13.10.2022Renewal fee patent year 12
29.09.2023Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption30.12.2014Interruption of proceedings. Reason: legal prevention of applicant[2015/28]
02.11.2021Resumption of proceedings[2021/19]
30.12.2014Interruption of proceedings. Reason: legal prevention of applicant[2021/19]
Lapses during opposition  TooltipHU10.11.2011
BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
MC27.03.2024
PL27.03.2024
RO27.03.2024
SE27.03.2024
SI27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
IE10.11.2024
LU10.11.2024
[2026/16]
Former [2025/52]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
MC27.03.2024
PL27.03.2024
RO27.03.2024
SE27.03.2024
SI27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
IE10.11.2024
LU10.11.2024
Former [2025/48]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
MC27.03.2024
PL27.03.2024
SE27.03.2024
SI27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
IE10.11.2024
LU10.11.2024
Former [2025/34]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
MC27.03.2024
PL27.03.2024
SE27.03.2024
SI27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
LU10.11.2024
Former [2025/33]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
MC27.03.2024
PL27.03.2024
SE27.03.2024
SI27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2025/22]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
PL27.03.2024
SE27.03.2024
SI27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2024/49]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
PL27.03.2024
SE27.03.2024
SK27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2024/48]BG27.03.2024
CZ27.03.2024
EE27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2024/47]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
SM27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
PT29.07.2024
Former [2024/46]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
IS27.07.2024
Former [2024/37]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
SE27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
Former [2024/36]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
LV27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
Former [2024/34]BG27.03.2024
FI27.03.2024
HR27.03.2024
LT27.03.2024
NO27.06.2024
RS27.06.2024
GR28.06.2024
Former [2024/33]LT27.03.2024
NO27.06.2024
Cited inInternational search[X] WO0002600  (ENCELLE INC et al.)
 [YD] WO2010056328  (TENGION INC et al.)
 [A] JPS63174934  
 [A] WO2007095193  (TENGION INC et al.)
 [Y]   "Reversible Polymeric Gels and Related Systems", vol. 350, 14 September 1987, AMERICAN CHEMICAL SOCIETY, Washington, DC, article MADELEINE DJABOUROV ET AL: "Thermally Reversible Gelation of the Gelatin-Water System", pages: 211 - 223, XP055021583

DOI:   http://dx.doi.org/10.1021/bk-1987-0350.ch014
 [A]   RESAT APAK: "Comparative evaluation of Various Total Antioxidant Capacity Assays Applied to Phenolic Compounds with the CUPRAC Assay", MOLECULES, 1 January 2007 (2007-01-01), pages 1496 - 1547, XP055021584, Retrieved from the Internet [retrieved on 20120312]

DOI:   http://dx.doi.org/10.3390/12071496
 [A]   SAKAI S ET AL: "An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 30, no. 20, 1 July 2009 (2009-07-01), pages 3371 - 3377, XP026104367, ISSN: 0142-9612, [retrieved on 20090405], DOI: 10.1016/J.BIOMATERIALS.2009.03.030

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2009.03.030
 [A]   KUIJPERS A J ET AL: "CROSS-LINKING AND CHARACTERISATION OF GELATIN MATRICES FOR BIOMEDICAL APPLICATIONS", JOURNAL OF BIOMATERIALS SCIENCE. POLYMER EDITION, VSP, UTRECHT, NL, vol. 11, no. 3, 1 January 2000 (2000-01-01), pages 225 - 243, XP001016160, ISSN: 0920-5063, DOI: 10.1163/156856200743670

DOI:   http://dx.doi.org/10.1163/156856200743670
 [A]   DATABASE WPI Week 198834, Derwent World Patents Index; AN 1988-240131, XP002671248
ExaminationUS6224893
by applicantUS6991652
 WO2010056328
 US2011036347
 US2011117162
 US2011039859
 US2010131075
 US2011035058
 US6576019
 US2007276507
 US6224893
 US2011053157
 US6283761
 US6306406
 US6346274
 US2002182254
 US2002051808
 US7563822
   ROHANIZADEH ET AL., J MATER SCI MATER MED, vol. 19, 2008, pages 1173 - 1182
   TAKEMOTO ET AL., TISSUE ENG PART A, vol. 14, 2008, pages 1629 - 1638
   YOUNG ET AL., J CONTROL RELEASE, vol. 109, 2005, pages 256 - 274
   CENNI ET AL., J BIOMATER SCI POLYM ED, vol. 1, 2000, pages 685 - 699
   LEE ET AL., INT J PHARM, vol. 221, 2001, pages 1 - 22
   WAKSMAN ET AL., J IMMUNOL, vol. 63, 1949, pages 427 - 433
   ENGVALL ET AL., INT J CANCER, vol. 20, 1977, pages 1 - 5
   KIM ET AL., ORAL SURG ORAL MED ORAL PATHOL ORAL RADIOL ENDOD, vol. 108, 2009, pages E94 - 100
   ADHIRAJAN ET AL., J MICROENCAPSUL, vol. 24, 2007, pages 647 - 659
   CHANG ET AL., MACROMOL BIOSCI, vol. 7, 2007, pages 500 - 507
   GAGNIEU ET AL., BIOMED MATER ENG, vol. 17, 2007, pages 9 - 18
   KIMURA ET AL., J BIOMATER SCI POLYM ED, vol. 21, 2010, pages 463 - 476
   MA ET AL., J BIOMED MATER RES A, vol. 71, 2004, pages 334 - 342
   VANDELLI ET AL., INT J PHARM, vol. 215, 2001, pages 175 - 184
   VANDELLI ET AL., J CONTROL RELEASE, vol. 96, 2004, pages 67 - 84
   KOMMAREDDY ET AL., NANOMEDICINE, vol. 3, 2007, pages 32 - 42
   SEHGAL ET AL., EXPERT OPIN DRUG DELIV, vol. 6, 2009, pages 687 - 695
   SUTTER ET AL., J CONTROL RELEASE, vol. 119, 2007, pages 301 - 312
   OLDE DAMINK ET AL., BIOMATERIALS, vol. 17, 1996, pages 765 - 773
   PIEPER ET AL., BIOMATERIALS, vol. 21, 2000, pages 581 - 593
   CORNWELL ET AL., CLIN PODIATR MED SURG, vol. 26, 2009, pages 507 - 523
   LAI ET AL., J MATER SCI MATER MED, vol. 21, 2010, pages 1899 - 1911
   R LANZA, R LANGER, & J VACANTI: "Principles of Tissue Enizineeriniz, 3rd Ed.", 2007
   BASU ET AL., LIPIDS IN HEALTH AND DISEASE, vol. 10, 2011, pages 171
   THERY ET AL., NAT. REV. IMMUNOL., vol. 9, 2010, pages 581 - 593
   ZHOU ET AL., KIDNEY INT., vol. 74, no. 5, 2008, pages 613 - 621
   ALFONSO R GENNARO: "Remington: The Science and Practice of Pharmacy, formerly Remington's Pharmaceutical Sciences 20th ed.,", 2003, LIPPINCOTT, WILLIAMS & WILKINS
   J. R. ROBINSON,: "Sustained and Controlled Release Drug Delivery Systems", 1978, MARCEL DEKKER, INC.
   LV ET AL., J BIOMED MATER RES A, vol. 84, 2008, pages 198 - 207
   BASU ET AL., CELL TRANSPLANTATION, 2011
   KELLEY ET AL., AM J PHYSIOL RENAL PHYSIOL., vol. 299, no. 5, 8 September 2010 (2010-09-08), pages F1026 - 39
   RANGAN ET AL., FRONT BIOSCI, vol. 12, 2009, pages 3496 - 3522
   SANZ ET AL., JAM SOC NEPHROL, vol. 21, 2010, pages 1254 - 1262
   ZEISBERG ET AL., NAT MED, vol. 9, 2003, pages 964 - 968
   SEO ET AL., AM J NEPHROL, vol. 30, 2009, pages 481 - 490
   THERY ET AL., NAT REV IMMUNIOL, vol. 9, 2010, pages 581 - 593
   ALIOTTA ET AL., EXP HEMATOL, vol. 38, 2010, pages 233 - 245
   ABOUSHWAREB ET AL., WORLD J UROL, vol. 26, 2008, pages 295
   REROLLE ET AL., KIDNEY INT, vol. 58, 2000, pages 1841
   WANG ET AL., NUC ACIDS RES, 7 July 2010 (2010-07-07), pages 1 - 12
   MARQUEZ RT ET AL., AM J PHYSIOL GASTROINTEST LIVER PHYSIOL, vol. 298, 2010, pages G535
   TAGANOV KD ET AL., PROC NATL ACAD SCI USA, vol. 103, 2006, pages 12481
   ZEISBERG ET AL., AM J PATHOL, vol. 160, no. 6, 2002, pages 2001 - 2008
   DUDAS ET AL., NEPHROL DIAL TRANSPLANT, vol. 24, no. 5, 2009, pages 1406 - 1416
   HILLS ET AL., AM J PHYSIOL RENAL PHYSIOL, vol. 296, no. 3, 2009, pages F614 - 621
   KELLY ET AL., J AM SOC SOC NEPHROL, 1999
   ZHOU ET AL., KIDNEY INT., vol. 74, no. 5, September 2008 (2008-09-01), pages 613 - 621
   ROMAGNANI P; KALLURI R., FIBROGENESIS TISSUE REPAIR., vol. 2, no. 1, 2009, pages 3
   LIE ET AL., NATURE, vol. 437, no. 7063, 2005, pages 1370 - 5
   WILLERT ET AL., NATURE, vol. 423, no. 6938, 2003, pages 448 - 52
   LI ET AL., AM J PHYSIOL RENAL PHYSIOL., vol. 297, no. 6, 2009, pages F1526 - 33
   GUO ET AL., J HEPATOL., vol. 50, no. 4, 2009, pages 766 - 78
   XIA ET AL., BIOCHEM BIOPHYS RES COMMUN., vol. 380, no. 2, 2009, pages 205 - 10
   SAAL ET AL., CURR. OPIN. NEPHROL. HYPERTENS, vol. 18, 2009, pages 317 - 323
   TAGANOV ET AL., PROC NATL ACAD SCI U S A., vol. 103, no. 33, 2006, pages 12481 - 6
   GRIFFITHS-JONES ET AL., NAR, vol. 34, 2006, pages D140 - D144
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.